ENTRY       D12144                      Drug
NAME        Orilanolimab (USAN/INN)
FORMULA     C6288H9876N1696O2016S42
EXACT_MASS  142747.0684
MOL_WEIGHT  142834.5806
SEQUENCE    (Heavy chain)
            QVQLVQSGAE LKKPGASVKL SCKASGYTFT SYGISWVKQA TGQGLEWIGE IYPRSGNTYY
            NEKFKGRATL TADKSTSTAY MELRSLRSED SAVYFCARST TVRPPGIWGT GTTVTVSSAS
            TKGPSVFPLA PCSRSTSEST AALGCLVKDY FPEPVTVSWN SGALTSGVHT FPAVLQSSGL
            YSLSSVVTVP SSSLGTKTYT CNVDHKPSNT KVDKRVESKY GPPCPPCPAP EFLGGPSVFL
            FPPKPKDTLM ISRTPEVTCV VVDVSQEDPE VQFNWYVDGV EVHNAKTKPR EEQFNSTYRV
            VSVLTVLHQD WLNGKEYKCK VSNKGLPSSI EKTISKAKGQ PREPQVYTLP PSQEEMTKNQ
            VSLTCLVKGF YPSDIAVEWE SNGQPENNYK TTPPVLDSDG SFFLYSRLTV DKSRWQEGNV
            FSCSVMHEAL HNHYTQKSLS LSLG
            (Light chain)
            DIQMTQSPSS LSASVGDRVT ITCKASDHIN NWLAWYQQKP GQAPRLLISG ATSLETGVPS
            RFSGSGTGKD YTLTISSLQP EDFATYYCQQ YWSTPYTFGG GTKVEIKRTV AAPSVFIFPP
            SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT
            LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC
            (Disulfide bridge: H22-H96, H132-L214, H145-H201, H224-H'224, H227-H'227, H259-H319, H365-H423, H'22-H'96, H'132-L'214, H'145-H'201, H'259-H'319, H'365-H'423, L23-L88, L134-L194, L'23-L'88, L'134-L'194)
  TYPE      Peptide
EFFICACY    Autoimmune disease treatment
  TYPE      Monoclonal antibody
COMMENT     Treatment of IgG-mediated autoimmune disorders
TARGET      FCGRT [HSA:2217] [KO:K24019]
BRITE       Target-based classification of drugs [BR:br08310]
             Not elsewhere classified
              Organismal systems
               Immune system
                FCGRT
                 D12144  Orilanolimab (USAN/INN)
DBLINKS     CAS: 2066544-85-0
///
